| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.29 | 0.0001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.0003 |